A huge crowd gathered at Harvard Business School’s Burden Auditorium for the school’s annual business plan/pitch contest on Tuesday. Dubbed the HBS New Venture Competition, the event was one of the more spectacular entrepreneur contests held…
To Dean Nitin Nohria, Tuesday’s New Venture Competition was proof “entrepreneurship of all kinds can thrive” at Harvard Business School. One glance at the contest’s
The Harvard Innovation Lab has been open for business just over a year. Led by managing director Gordon Jones and his team of startup hustlers, the Allston, MA-based community space for student entrepreneurs is just hitting its stride, with a number of current and former residents making noise in the local…
Vaxess Technologies, a start-up that’s developing refrigeration-free vaccines, got into Harvard! If Vaxess had parents, they’d be proud — especially considering that the developers of its core technologies — Fiorenzo Omenetto and David Kaplan — are professors at Tufts University.
By getting into Harvard, I mean that Vaxess’s team is…
Who would guess that silkworm cocoons – the raw material for silk thread – could replace vaccine refrigeration transit? This innovative application of a “natural” product is an emerging reality, thanks to Vaxess Technologies, a Cambridge-based biotech company…
Read more
KEEPING drugs, and particularly vaccines, potent in tropical climes is a challenge. Heat tends to damage them. Such medicines have therefore to be passed from one refrigerator to another, along what is referred to as a cold chain, until they arrive at the clinics whence they are to be deployed. Fridges, however, are expensive. They…
We’re joined by a winner of Harvard’s President’s Challenge for social entrepreneurship, Michael Schrader.
His team knew that, every year, more than two million people around the world die due to diseases that we actually have vaccines for, because so many vaccines need refrigeration. And it can be incredibly difficult to get…
Read more
Keeping vaccines cold enough for them to survive is one of the largest challenges of global health efforts. A new breakthrough uses silk to dramatically increase the temperature at which a vaccine can live–which could save millions…
A MassChallenge finalist whose goal is to improve the delivery of vaccines in developing countries has been selected as the grand prize winner of the Harvard University President’s Challenge for social entrepreneurship.
Vaxess Technologies, a Cambridge-based company founded by four Harvard students and alumni, will receive $70,000 for its plan to commercialize new technology that will allow vaccines to…
A business idea born in a Harvard classroom to improve the delivery of vaccines in developing countries has been selected as the grand prize winner of the Harvard University President’s Challenge for social entrepreneurship.
Vaxess Technologies, a Cambridge-based company founded by students from across Harvard, will receive $70,000 to support a plan to commercialize new technology that…
Read moreCopyright © 2011 Vaxess. All rights reserved.